BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 9 filers reported holding BIO BLAST PHARMA LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $17,000 | – | 22,471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 206,054 | $214,000 | 0.38% |
| Anson Funds Management LP | 270,793 | $282,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 660,157 | $687,000 | 0.04% |
| OPPENHEIMER & CO INC | 24,700 | $26,000 | 0.00% |
| UBS Group AG | 4,066 | $4,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,255 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 15,032 | $16,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $1,000 | 0.00% |
| BlackRock Fund Advisors | 16,786 | $17,000 | 0.00% |
| MORGAN STANLEY | 1,026 | $2,000 | 0.00% |